Physician

Alfred O Greco, MD

According to 2025 Medicare claims, Alfred Greco, MD (NPI: 1073501607) practices medical oncology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is WASHINGTON UNIVERSITY PHYSICIANS IN ILLINOIS, INC (NPI: 1477076263; TIN: 822026363) and primary practice location at 62002-6751.

Greco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 232 traditional Medicare patients, billed 513 HCPCS/CPT codes, and received $38,174 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,829 prescription claims across 306 beneficiaries totaling $2,637,434 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 32 claims. Open Payments data shows 4 records totaling $75. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,026,812 and ending at $38,174. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $508,426 to $2,637,434. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	690	67,416	$1,026,812
2016	594	73,016	$944,399
2017	630	74,041	$1,283,625
2018	672	80,774	$1,413,505
2019	627	121,041	$2,001,598
2020	543	66,858	$933,337
2021	606	103,820	$1,921,333
2022	666	71,448	$1,142,504
2023	346	797	$47,242
2024	232	513	$38,174

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	1,570	$508,426
2016	236	1,390	$650,216
2017	266	1,674	$1,065,858
2018	249	1,339	$666,735
2019	246	1,511	$997,568
2020	268	1,881	$1,850,842
2021	314	2,384	$2,736,272
2022	393	2,169	$2,428,525
2023	334	1,776	$2,222,366
2024	306	1,829	$2,637,434

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	33	$3,320
2016	N/R	11	$407
2017	N/R	36	$7,740
2018	N/R	49	$8,459
2019	N/R	52	$4,450
2020	N/R	30	$3,403
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	32	$743

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	44	44	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	60	82	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	29	29	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	117	229	$69
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	90	122	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	45	1,324	$505,630
Revlimid	Lenalidomide	22	616	$452,988
Tagrisso	Osimertinib Mesylate	21	604	$371,881
Xtandi	Enzalutamide	12	360	$158,834
Eliquis	Apixaban	64	2,047	$39,846

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$460
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$282

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$75	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfred O. Greco, MD?

Tedicare shows public-source Medicare data for Alfred O. Greco, MD (NPI 1073501607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfred O. Greco, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alfred O. Greco, MD?

Alfred O. Greco, MD is linked to WASHINGTON UNIVERSITY PHYSICIANS IN ILLINOIS, INC (billing NPI 1477076263) in the available physician profile data.

Does Alfred O. Greco, MD have Open Payments data?

Alfred O. Greco, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.